STUDIES ON AMLAPITTA W.S.R. TO RAKTADUSTI & RAKTAJA ROGA by Porel, *Kaushik & Ray, Sukalyan
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
  IJAPR | July 2017 | Vol 5 | Issue 7  74 
International Journal of Ayurveda  




STUDIES ON AMLAPITTA W.S.R. TO RAKTADUSTI & RAKTAJA ROGA 
Kaushik Porel1*, Sukalyan Ray2 
*1P.G. Scholar, Dept. of Roga Nidan, I.P.G.A.E.R. at S.V.S.P. & Hospital, Kolkata, West Bengal, India. 
2Assistant professor, Dept. of Roga Nidan, Raghunath Ayurved Mahavidyalaya & Hospital, Contai, West Bengal, India. 
ABSTRACT 
Amlapitta is a disease where there is vitiation of Pitta dosha in general and Amla Guna of Pitta in specific. In the 
primary compendiums, the disease Amlapitta has not been mentioned separately. This disease was first 
described as a separate entity in Madhav Nidan, and thereafter in Kashyap Samhita and Bhavprakash. Although 
Acharya Charak has not mentioned this disease separately, the causative factor and clinical feature of 
Raktadusti and Raktaja Roga mentioned by him are very similar to that of Amlapitta. Pitta and Rakta are two 
identical elements of body. Due to the similarities in between Pitta and Rakta, the former afflicts more the later. 
In this study, the literary information regarding the similarities between Raktadusti, Raktaja Roga and 
Amlapitta have been verified through clinical study. A comparative discussion has been carried out between the 
causative factors and clinical features of Raktadusti, Raktaja Roga and Amlapitta. The study has been also 
carried out to evaluate the efficacy of Amlaki (Emblica officinalis Gaertn.), which is a well-known drug clinically 
effective on Raktadusti and Raktaja Roga due to its Tikta, Madhura and Kashaya rasa, Madhur Vipaka and Sheeta 
Virya. This subsequently helps to combat Amlapitta. Fresh juice of fruit pulp of Amlaki (Emblica officinalis 
Gaertn.) was administered in the selected 30 patients at a dose of 50 ml per day, at early morning and in empty 
stomach for a period of 21 days. After 21 days, effect of the stipulated drug was evaluated in 27 patients with 3 
dropouts. The subjective and objective parameters have been evaluated before and after treatment. All the 
findings have been statistically analyzed using paired ‘t’ test. The obtained results have been interpreted as – p 
<0.05 is significant & p <0.001 is highly significant. The results showed ‘p’ value <0.001 in most of the 
parameters (subjective and objective), which indicates that, the drug taken for the present study i.e. Amalaki is 
highly efficacious against Raktadusti & Raktaja Roga and subsequently very helpful to combat Amlapitta.  
KEYWORDS: Amlapitta, Pitta, Rakta, Raktadusti, Raktaja roga. 
INTRODUCTION
 Amlapitta is an important disease in today’s fast-
growing society where there is much alteration of food 
habit and life style. Although it is one of the most 
commonly encountered disorders in clinics now a day, it is 
not categorically described in our principal compendiums. 
The categorical description of the disease Amlpitta is first 
available in Madhav Nidan and later it is found in Kashyap 
Samhita as well as Bhavprakash.[1-3] Being the foremost 
compendium, Charak Samhita has not given any detailed 
description about this disease. Many modern-day scholars 
have opined that, the features of Pittaja Grahani as 
described by Acharya Charak are very similar to 
Amlapitta.[4] But along with that, Acharya Charak has also 
given a detailed description of different disorders due to 
alteration of Rakta Dhatu (Raktadusti) along with the 
causative factors and their principle of management. [5] The 
interesting fact about these disorders caused by Raktadusti 
is that, majority of the disorders (mainly as symptoms and 
signs) are similar to the clinical features found in 
Amlapitta. Moreover, the causative factors of Raktadusti 
are similar to those of Amlapitta.[6,7] Pitta and Rakta are 
similar in nature and due to that; the aggravated Pitta 
afflicts Rakta more than other Dhatus. Study of Amlapitta 
in the context of Raktadusti and Raktaja Roga has not been 
done yet. So, in the above context, this study was carried 
out to evaluate Amlapitta on the basis of Raktadusti and 
Raktaja Roga.  
 In the disease Amlapitta there is vitiation of Amla 
Guna of Pitta specifically “Amlagunodrikta Pittamamla- 
pittam”.[8] Pitta and Rakta have very similarities in terms of 
Gandha, Varna & Guna.[9] Acharya Vagbhat has mentioned 
that, Pitta dosha remains as Ashrayi i.e. sheltered in Rakta 
Dhatu which acts as Ashraya i.e. shelter, due to their 
homologues character.[10] Acharya Charak has also 
mentioned Pitta as the Mala of Rakta.[11] According to 
Madhav Nidan, due intake of improper diet and regimen, 
the already accumulated Pitta during its natural 
accumulation season i.e. Rainy season, gets aggravated and 
causes Amlapitta, mostly in Autumn.[12] Charak has also 
stated that the Rakta Dhatu gets vitiated mainly during 
Sharad Kaala i.e. autumn season.[13] Besides these facts, 
there are plenty of similarities between the causative 
factors of Raktadusti (as mentioned by Charak Samhita) 
and Amlapitta (as mentioned by Madhav Nidan & Kashyap 
Samhita), which will be very helpful to assess Amlapitta in 
the line of Raktadusti & Raktaja Roga. Here we have 
considered Raktadusti & Raktaja Roga together because of 
the fact that, Acharya Charak has mentioned all the Raktaja 
Roga occurs due to vitiation of Rakta i.e. Raktadusti as 
consequence of Nidansevan.[14] Acharya Charakhas also 
mentioned that all the Raktaja Roga occur afflicting the 
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Rakta Dhatu- ‘Shonitashraya’.[15] Therefore presence of 
similar features like several Raktaja Roga in the disease 
Amlapitta validates Raktadusti as a pathological event in 
Amlapitta. 
A comparative study of the causative factors of Raktadusti 
and Amlapitta are given below: 
Table 1: Comparative Study between causative factors of Rakta Dusti & Amlapitta[16] [17] 
Sl. No. Causative Factor Raktadusti Amlapitta  
01. Vidahi Dravya ++ ++ 
02. Dusta Dravya ++ ++ 
03. Amla Dravya ++ ++ 
04. Viruddhashan ++ ++ 
05. Adhyashan ++ ++ 
06. Ajeerna ++ ++ 
07. Ama -- ++ 
08. Pishtanna -- ++ 
09. Apakkva Madya ++ ++ 
10. Guru Bhojan ++ ++ 
11. Vishyandi Bhojan -- ++ 
12. Vegdharan ++ ++ 
13. Atyushna Dravya ++ ++ 
14. Snigdha Dravya ++ ++ 
15. Ruksha Dravya ++ ++ 
16. Amla Dravya ++ ++ 
17. Drava Dravya ++ ++ 
18. Phanita, Ikshuvikar -- ++ 
19. Kulattha ++ ++ 
20. Divaswapna ++ ++ 
21. Atisnana -- ++ 
22. Avagahan __ ++ 
23. Antara Udakpana -- ++ 
24. Paryushita Bhojan ++ ++ 
25. Anupa Desha ++ ++ 
26. Sharad Kaala ++ ++  
The pathological conditions which are mentioned as Raktaja Roga by Acharya Charak are combination of independent 
disease as well as sign and symptoms. Among them many identical features are also found in Amlapitta. Studies of these 
features help us to understand the character of Amlapitta and its evaluation in the line of Raktadusti & Raktaja Roga. A 
comparative study has been given below between the Raktaja Roga and the clinical features found in Amlapitta.  
Table 2 :Comparative Study between Raktaja Roga & features of Amlapitta[18] 
Sl. No. Pathological Condition Raktaja Roga General Feature of Amlapitta 
01. Avipaka ++ ++ 
02. Klama ++ ++ 
03. Utklesha ++ ++ 
04. Tikta Amla Udgar ++ ++ 
05. Gaurav ++ ++ 
06. Hrit Kantha Daha -- ++ 
07. Aruchi ++ ++ 
    
Sl. No. Pathological Condition Raktaja Roga Feature of Urdhaga Amlapitta 
01. Tikta Amla Vami ++ ++ 
02. Udgara -- ++ 
03. Hrit, Kantha, Kukshi Daha -- ++ 
04. Shira Ruja ++ ++ 
05. Kara CharanaDaha -- ++ 
06. Jwar ++ ++ 
07. Aruchi ++ ++ 
08. Kandu ++ ++ 
09. Mandal ++ ++ 
10. Peedaka ++ ++ 
    
 Kaushik Porel, Sukalyan Ray. Studies on Amlapitta w.s.r. to Raktadusti & Raktaja roga  
 IJAPR | July 2017 | Vol 5 | Issue 7  76 
Sl. No. Pathological Condition Raktaja Roga Feature of Adhoga Amlapitta 
01. Trishna ++ ++ 
02. Daha -- ++ 
03. Murchha ++ ++ 
04. Bhrama, Moha ++ ++ 
05. Hrillas __ ++ 
06. Kotha ++ ++ 
07. Analasaada ++ ++ 
08. Sweda ++ ++ 
09. Anga Peetatwakar + (as Vaivarna) ++ 
 In context of similarity between causative factors 
of Rakta Dusti and Amlapitta as well as similarity between 
Raktaja Roga and features of Amlapitta, the present study 
was carried out to evaluate. 
1. Concept of Raktadusti & Raktaja Roga. 
2. Evaluation of Amlapitta in the line of Raktadusti & 
Raktaja Roga.  
3. To assess efficacy of the selected drug i.e. Amlaki 
(Emblica officinalis Gaertn), a well-known drug 
indicated for Raktadusti, in the management of 
Amlapitta. 
Materials and Methods 
 The literary information regarding the similarities 
between Raktadusti, Raktaja Roga and the causative factor 
and clinical features of Amlapitta ware verified through 
clinical study. Assessment of homologous features of 
Raktaja Roga and Amlapitta were done on the basis of 
subjective and objective criteria. The study was also 
carried out to evaluate the efficacy of Amlaki (Emblica 
officinalis Gaertn.) as a Raktadoshahara drug in the 
management of Amlapitta. Amlaki is a well-known drug 
which is effective in Raktadusti and Raktaja Roga. This 
drug was administered in the patients included in the 
study to observe the improvement of subjective and 
objective criteria. The subjective and objective criteria 
were evaluated before and after treatment. 
Selection of Patients 
 30 patients were selected from OPD of IPGAE&R, 
at SVSP hospital irrespective of their sex, occupation and 
religion. The patients having the Lakshan of Amlapitta 
were selected for the study and subsequently the features 
of Raktajaroga were evaluated on the basis of subjective 
and objective parameters. Prior to carry out the study the 
informed patient consent form was duly signed by the 
patients.  
Inclusion Criteria 
1. Patients should have the sign and symptoms of 
Amlapitta. 
2. Patients above 20 years of age and below 50 years of 
age, irrespective of their occupation, sex and religion. 
3. Patients who are willing to include themselves into the 
study. 
4. Primarily detected Amlapitta patient, not taking any 
type of medication. 
5. Primarily detected Amlapitta patient without any 
other chronic and acute disease.  
Exclusion Criteria 
1. Patients below 20 years and above 50 years of age. 
2. Patients who are not willing to include themselves into 
the study. 
3. Diagnosed case of duodenal and gastric ulcer. 
4. Patient with significant hepatic, renal, hematological, 
neurological or psychiatric disorders.  
5. Patients of gastric carcinoma or Zollinger – Ellison 
syndrome were excluded from the study. 
Subjective Parameter 
 The subjective parameters were selected 
considering the identical features between Raktadutsi, 
Raktaja Roga and Amlapitta, as mentioned in aforesaid 
texts of Ayurveda. These are: 
1. Avipak (indigestion) 
2. Klama (exhaustion without any exertion)  
3. Tikta Amla Udgara (sour –bitter eructation)  
4. Gaurav (heaviness) 
5. Aruchi (loss of appetite) 
6. Trishna (thirst) 
7. Sweda (sweating) 
8. Shiraruja (headache)  
9. Kandu (itching) 
10. Agnisad (diminished digestive capacity)  
Objective Parameter 
The objective parameters were selected considering the 
pathological changes in blood i.e. Rakta in Amlapitta. These 
are: 
1. Blood for TC, DC, Hb%, ESR  
2.  Blood for LFT.  
Adoption of Drug 
 Amlaki (Emblica officinalis Gaertn.) is a plant, which is 
clinically effective on Raktadusti & Raktaja Roga and 
subsequently combat Amlapitta by the virtue of its Tikta, 
Madhura and Kashaya rasa, Madhur Vipaka and Sheeta 
Virya.[19,20] Fresh juice of fruit pulp of Amlaki (Emblica 
officinalis Gaertn.) was administered in the selected 
patients at a dose of 50 ml per day, at early morning and 
in empty stomach for a period of 21 days. After 21 days, 
effect of the stipulated drug was evaluated.  
Pathyapathya 
 Patient was advised to avoid Katu, Amla, Lavanarasa, 
Navanna, Viruddhaanna, Guru anna, Tailabhaksna, Tila, 
Masa, Kulattha, Avidugdha, Dadhi, Madya, Vega dharan, 
Pitta-prokopa activity etc. [21] 
Study Protocol 
Duration of study 
The duration of the study was 21 days.  
Assessment Criteria 
 Assessment was done on the basis of subjective and 
objective criteria before and after treatment. For the 
statistical evaluation each of the subjective parameters 
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have been arranged as per gradation[22] as mentioned 
below and evaluated thereafter.  
1. Avipak  
Grade Feature 
0 Absent 
1 Occasional indigestion once or twice a week 
2 3-5 times after both meals in a week 
3 After every meal  
2. Klama  
Grade Feature 
0 Absent 
1 Present but daily work schedule not disturbed 
2 Present and daily work schedule impaired 
3 Inability to perform daily work  
3. Tikta Amla Udgar 
Grade Feature 
0 Absent 
1 Rare and not aggravated by spicy food 
2 Intermittent and aggravated by spicy food  
3 Continuous and aggravated by any type of food  
4. Gaurav 
Grade Feature 
0 No feeling of heaviness 
1 Occasional heaviness in body but can perform 
normal work 
2 Continuous heaviness which hampers normal 
work 
3 Unable to do any work due to heaviness  
5. Aruchi  
Grade Feature 
0 Normal desire for food  
1 Eating timely without much desire 
2 Desire for food only after long intervals 
3 No desire at all 
6. Trishna  
Grade Feature 
0 Absent 
1 Present but daily work schedule not disturbed 
2 Present and daily work schedule impaired 
3 Inability to perform daily work  
7. Sweda  
Grade Feature 
0 Normal sweating according to climate and 
temperature  
1 Sweating after heavy work and in humid 
climate  
2 Sweating after moderate work, at 
comparatively low temperature 
3 Sweating all over the year, at resting condition 
& impairs daily life 
8. Shiraruja  
Grade Feature 
0 Absent 
1 Intermittent and relieved by Pathyas 
2 Continuous, not relieved by Pathyas but 
relieved by medicines  
3 Continuous, not relieved by rest or medicines 
9. Kandu  
Grade Feature 
0 Absent 
1 Rarely with aggravation of other symptoms of 
Amlapitta 
2 Intermittent with presence of cardinal 
symptoms of Amlapitta  
3 Continuous with or without presence of 
symptoms of Amlapitta 
10. Agnisad  
Grade Feature 
0 Presence of appetite at the time of principle 
meal and no discomfort what so ever after 
taking any food 
1 Feeling of heaviness after intake of heavy meal, 
for 3-4 hours with diminished appetite 
2 Feeling of heaviness and discomfort after 
taking moderate to heavy meal even at the 
time of next principle meal with loss of 
appetite  
3 Feeling of heaviness, bloating along with 
discomfort after taking any quantity of meal, 
remains throughout the day with complete 
loss of appetite  
Follow up of patients 
 All the patients were reviewed after 21 days from 
the date of administration of first dose. Any special 
information regarding the general health of the patient 
was recorded accordingly.  
Study sample 
 Total 30 patients of Amlapitta with features of Rakta 
Dusti & Raktaja Roga were included in the study.  
Statistical analysis 
 The information gathered on the basis of 
observation made about various parameters was 
subjected to statistical analysis in terms of Mean, 
Standard Deviation (SD) and Standard Error (SE). Paired 
‘t’ test was carried out at P<0.05 and P<0.001. The 
obtained results were interpreted as -P<0.05 is significant 
& P<0.001 is highly significant. 
Observations and Results 
 Among the 30 patients total 3 patients were 
dropped out during study course. Hence complete clinical 
survey was done in 27 patients. Distribution of subjective 
parameters of Raktadusti & Raktaja Roga among the 27 
patients of Amlapitta shows that, Avipak present in 27 
patients (100%), Klama present in 25 patients (92.6%), 
Tikta Amla Udgara present in 27 patients (100%), Gourav 
present in 21 patient (77.8%), Aruchi present in 27 
patient (100%), Trisna present in 24 patient (88.9%), 
Sweda present in 24 patient (88.9%), Siraruja present in 
22 patient (81.5%), Kandu present in 18 patient (66.7%), 
Agnisad present in 27 patient (100%) [table no. 3]. 
Statistical analysis of subjective and objective parameters 
in 27 patients of Amlapitta before and after treatment 
shows that Amlaki has significant efficacy on both the 
subjective and objective parameters with ‘p’ value <0.001. 
[table no. 4]. 
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Table 3 : Distribution of the subjective parameters in 27 patients of Amlapitta 
Sl. No. Subjective Parameters Number of Patient Percentage 
01. Avipak 27 100% 
02. Klama 25 92.6% 
03. Tikta Amla Udgara 27 100% 
04. Gaurav 21 77.8% 
05. Aruchi 27 100% 
06. Trishna 24 88.9% 
07. Sweda 24 88.9% 
08. Shiraruja 22 81.5% 
09. Kandu 18 66.7% 
10. Agnisad 27 100% 
Table 4 : Showing the statistical analysis of subjective and objective parameters in 27 patients of Amlapitta before 
and after treatment 
Parameters Mean BT Mean AT SD +/- SE +/- ‘t’ value ‘p’ value 
Avipak 2.18 0.75 0.83 0.16 9.1 <0.001 
Klama 1.71 0.90 1.35 0.26 3.1 <0.05 
Tikta Amla Udgara 2.14 0.74 0.51 0.10 14.67 <0.001 
Gaurav 1.35 0.75 1.12 0.21 2.78 <0.05 
Aruchi 2.04 0.63 0.56 0.107 13.08 <0.001 
Trishna 2.0 0.68 0.63 0.12 10.98 <0.001 
Sweda 1.31 0.36 0.58 0.113 8.4 <0.001 
Shiraruja 1.86 0.9 0.57 0.10 8.76 <0.001 
Kandu 1.34 0.37 0.55 0.105 9.21 <0.001 
Agnisad 2.09 0.72 0.54 0.104 11.66 <0.001 
Hb% 11.6 11.8 0.35 0.068 2.96 <0.05 
ESR 18.70 18.25 3.83 0.74 0.61 >0.05 
SGOT 26.05 25.45 0.91 0.17 3.4 <0.05 
SGPT 25.65 25.0 1.05 0.20 3.2 <0.05 
Alkaline Phosphatase 90.20 88.80 4.20 0.81 1.703 >0.05 
DISCUSSION
 Pitta and Rakta are two identical elements of body, 
among them Rakta is afflicted by the vitiated Pitta very 
often. Amlapitta is a disease where there is excessive 
vitiation of Pitta in general and Amla Guna of Pitta in 
specific. The causative factors which are responsible for 
Pitta vitiation also cause Raktadusti. Thus there are many 
common factors present in the causative factors of both 
Raktadusti & Raktaja Roga as well as Amlapitta. 
Considering this the identical causative factors are 
tabulated in the Table1. Apart from the similar causative 
factors, maintaining the principle of pathology both the 
Raktaja Roga (as sign and symptoms) and Amlapitta has 
identical features, which are tabulated in the Table 2. 
These findings validate that there is Raktadusti in Raktaja 
Roga as well as Amlapitta. So, Amlapitta can also be 
considered as one of the type of Raktaja Roga.  
 Table 3 shows that, most of the cases included under 
the present study were satisfying all the subjective 
criteria, which are identical features between Raktadusti, 
Raktaja Roga and Amlapitta. It signifies that, the textual 
understanding regarding Raktaja Roga and Amlapitta can 
be validated clinically.  
 Table 4 shows the statistical analysis before and 
after administration of the drug Amlaki. This table shows 
the ‘p’ value <0.001 in most of the parameters (subjective 
and objective), which indicates that, the drug taken for the 
present study is highly efficacious against Raktadusti & 
Raktaja Roga and subsequently against Amlapitta. Amlaki 
acts against Raktadusti which in turn cause Raktaja Roga, 
by virtue of its Tikta, Madhura and Kashaya Rasa, Madhur 
Vipaka and Sheeta Virya. This subsequently helps to 
combat Amlapitta and reduce the manifestation of clinical 
features.  
CONCLUSION 
 The Nidan of Raktadusti has a definite role to cause 
Amlpittaa part from Raktaja Roga. In all the patients of 
Amlapitta, Raktadustilakshan in form of Raktaja Roga are 
clinically present. The patients suffering from Amlapitta 
can be treated with the drugs responsible to arrest the 
Raktadusti and Raktaja Roga like Amlaki.  
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